Myasthenia gravis is one of the rarest and most concerning muscular disorders. Here's why.
Myasthenia gravis, or MG, is a chronic autoimmune neuromuscular disorder that causes muscle weakness and fatigue.
'Game-Changing' New Treatment for Asthma Is First in 50 Years
Scientists have found a new treatment for people with asthma and chronic obstructive pulmonary disease (COPD) that may be more effective than current options. Over the past 50 years, treatment options ...
First game-changing asthma attack treatment in 50 years; all you want to know
Researchers at King's College London have discovered a groundbreaking asthma treatment, Benralizumab, the first of its kind ...
Merck's therapy for rare lung condition shown to help reduce risk of death in study
Merck said on Monday its drug, Winrevair, helped significantly reduce the risk of death in patients with a rare condition ...
Parade on MSN3d
New Hair Loss Treatment May Impact Heart Health, According to Cardiologists
People may experience hair loss for various reasons—perimenopause, chemotherapy, alopecia and more. It’s also normal to find ...
Pulmonaryhypertensionnews.com3d
Winrevair excels at advanced PAH in Phase 3 trial, all offered treatment
Winrevair lowered death or transplant risk in adults with PAH functional class 3-4 at high risk of dying; all in study may ...
Vitamin B3 Could Revolutionize COPD Treatment: New Study Offers Hope for Millions
A new study suggests that nicotinamide riboside (a form of vitamin B3) may reduce lung inflammation in COPD patients, with ...
BioPharma Dive5d
New data could help Merck expand use of cardiovascular drug
Positive study results for Winrevair could help the drugmaker achieve sales growth past top-seller Keytruda’s upcoming patent ...
Science Daily9d
New study shows promising results for COPD treatment
A new study shows that a form of vitamin B3 can reduce lung inflammation in COPD patients. The researchers hope it will pave the way for new treatment options.